Q2'22 Earnings Call Presentation February 1, 2022 Agenda John Chiminski, Chair & Chief Executive Officer • Q2'22 highlights • CEO transition plan Alessandro Maselli, President & Chief Operating Officer • FY'26 financial targets Thomas Castellano, Senior VP & Chief Financial Officer • Q2'22 financial performance • Capitalization review • FY'22 financial guidance Question & Answer Session 2 Disclaimer Statement Forward-Looking Statements This release contains both historical and forward-looking statements. Al ...

Catalent. CATALENT, INC. INVESTOR PRESENTATION JANUARY 10, 2022 Catalent. Where science meets art. Forward-looking statements This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be iden ...

Catalent. Q1'22 Earnings Call Presentation November 2, 2021 DEVELOPMENT DELIVERY SUPPLY more products. better treatments. reliably supplied." Agenda | --- | |--------------------------------------------------------| | John Chiminski, Chair & Chief Executive Officer | | Q1'22 financial highlights | | Q1'22 operational highlights | | Thomas Castellano, Senior VP & Chief Financial Officer | | Q1'22 business segment financial performance | | EBITDA & Adjusted EBITDA | | Adjusted Net Income and Adjusted Net Inco ...

Catalent, Inc. (NYSE:CTLT) Q3 Earnings Conference Call November 2, 2021 8:15 AM ET Company Participants John Chiminski – Chair and Chief Executive Officer Paul Surdez – Vice President of Investor Relations Thomas Castellano – Senior Vice President and Chief Financial Officer Conference Call Participants Tycho Peterson – JP Morgan Jacob Johnson – Stephens David Windley – Jefferies Unidentified Analyst – Morgan Stanley John Kreger – William Blair Jack Meehan – Nephron Paul Knight – KeyBanc Capital Markets Tho ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 10-Q ______________________________ ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 001-36587 (Commission File Number) _____________________________ Catalent, Inc. (Exact name of registrant as specifi ...

Catalent, Inc. (NYSE:CTLT) Q4 2021 Earnings Conference Call August 30, 2021 8:15 AM ET Company Participants Paul Surdez - VP, IR John Chiminski - Chairman and CEO Thomas Castellano - SVP and CFO Conference Call Participants Tycho Peterson - JPMorgan Jacob Johnson - Stephens John Kreger - William Blair Dave Windley - Jefferies Sean Dodge - RBC Capital Juan Avendano - Bank of America George Hill - Deutsche Bank Operator Good day and thank you for standing by. Welcome to the Catalent, Inc. Fourth Quarter Fisca ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2021 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36587 CATALENT, INC. (Exact name of registrant as specified in its charter) Delaware 20-8737688 (State or other jurisdiction of incorporation or org ...

Catalent. Q4'21 Earnings Call Presentation August 30, 2021 DEVELOPMENT DELIVERY SUPPLY more products. better treatments. reliably supplied." Agenda | --- | |-----------------------------------------------------------| | | | John Chiminski, Chair & Chief Executive Officer | | • Q4'21 and FY'21 review | | • Bettera Wellness transaction overview | | Thomas Castellano, Senior VP & Chief Financial Officer | | • Q4'21 business segment financial performance | | • EBITDA & Adjusted EBITDA | | • Adjusted Net Income ...

Catalent. DEVELOPMENT DELIVERY May 4, 2021 more products. better treatments. reliably supplied." Q3'21 Earnings Call Presentation SUPPLY Agenda John Chiminski, Chair & Chief Executive Officer • Q3'21 review Wetteny Joseph, Senior VP & Chief Financial Officer • Q3'21 business segment financial performance • EBITDA & Adjusted EBITDA • Adjusted Net Income and Adjusted Net Income per Share • Capitalization review • FY'21 financial guidance Question & Answer Session 2 Disclaimer Statement Forward-Looking Stateme ...

Table of Contents Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbols(s) Name of each exchange on which registered Common Stock CTLT New York Stock Exchange UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 10-Q ______________________________ ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ¨ TRANSITION REPORT PURSUANT ...